SITC 30th Anniversary Annual Meeting (2015): Precision Immunology November 6-8, 2015 Gaylord National Hotel & Convention Center National Harbor, MDSession Co-Chairs Vincenzo Bronte, MD – University of Verona Keith L. Knutson, PhD – Mayo Clinic Jacksonville SITC 30th Anniversary Annual Meeting Organizers Sandra Demaria, MD – Weill Cornell Medical College Madhav Dhodapkar, MD – Yale University Pamela S. Ohashi, PhD – Princess Margaret Cancer Centre Jennifer A. Wargo, MD – University of Texas MD Anderson Cancer Center Andrew D. Weinberg, PhD – Earle A. Chiles Research InstituteProgram SummaryPrecision Immunology, like the broader field of Precision Medicine, seeks to customize therapies based on genetic or phenotypic groups of patients. In the case of Precision Immunology, this is based on immunological phenotypes, which are of particular interest for the application of new immunologically-based cancer therapies. As an example of this field, multiple studies recently showed that PD-1 and PD-L1 expression at tumor sites was predictive for melanoma patient responsiveness to PD-1-based immunotherapy. This session from the SITC 30th Anniversary Annual Meeting on Saturday, November 7, 2015 in National Harbor, MD expanded on this concept with speakers that discussed a range of related topics. Our invited speakers had done recent work showing the importance of the location of specific immune cell subsets in tumor biopsies, and the predictive power of neoepitope signatures derived from tumor DNA sequencing. Target Audience The target audience for this program included basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers that wished to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment. #2015 #AnnualMeeting #Biomarkers #ColorectalCancer #Melanoma #PresentationSlides #SITC #ImmuneCheckpointInhibitors #Clinician #Industry #Oncologist #Researcher #Video
Meeting: SITC 30th Anniversary Annual Meeting; Session: Precision Immunology; Presentation: Pre-existing Immunity and Treatment Outcome with Anti-PD1 Therapy in Melanoma; Presenter: Paul Tumeh, MD – University of California Los Angeles; Date: November 7, 201500:26:32
Meeting: SITC 30th Anniversary Annual Meeting; Session: Precision Immunology; Presentation: PD-1 Blockade in Mismatch Repair Deficient Tumors; Presenter: Luis A. Diaz, MD – Johns Hopkins Sidney Kimmel Cancer Center; Date: November 7, 201500:19:36
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us